OTC Healthcare in Norway
Euromonitor International's OTC Healthcare in Norway market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 91 | Publication date: Oct 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Deregulation creates competition
A new retail environment for OTC healthcare is evolving due to distribution deregulation by the Norwegian government in 2003. At the start of the review period, OTC healthcare had to be purchased from old-fashioned government-regulated chemists/pharmacies, where customers were served over a counter by pharmacists. By 2006, however, OTC healthcare could be purchased from grocery outlets, gas stations, kiosks and healthfood shops. The Institute for Norwegian Public Health stated that the value share of OTC healthcare sold in non-pharmacy outlets grew steadily from 2003. The Norwegian Medicine Authority meanwhile stated that deregulation created an environment offering fair price competition. Prices are consistently lower for leading brands in non-pharmacy distribution channels than in chemists/pharmacies.
Emergency contraception most dynamic due to growing awareness
Emergency contraception saw the most dynamic growth within OTC healthcare in 2006, with this due to growing awareness of these products. Despite distribution for these products being limited to chemists/pharmacies, availability still increased across the country, as there was a surge in the number of chemists/pharmacies present. Sales are expected to grow yet more rapidly during the forecast period if the government adopts its proposal to widen sales of emergency contraception to non-pharmacy outlets.
Building brands
Prior to the review period, Norwegians based their choice of OTC healthcare on advice from pharmacists, doctors or on personal experience. This situation changed since the deregulation of distribution in 2003, however. A 2006 research survey by the Norwegian Institute for Public Health showed that brand name was the most important criteria for 31% of respondents. Brand building is therefore increasingly important in selling OTC healthcare via non-pharmacy distribution channels. Consequently, many well-promoted and well-distributed brands gained share in 2006 over the previous year, such as Weifa’s Paracet and Cederroth’s Vitaplex.
Direct sales significant for vitamins and dietary supplements
Direct sales gained share dynamically in OTC healthcare during the review period, particularly in vitamins and dietary supplements. Vesterålens Naturaprodukter, Naturamed Pharma and Eurovita are among the largest Norwegian direct sales players, focusing on dietary supplements such as omega 3 and blueberry extract. In addition, many international direct sellers are present such as Nature’s Sunshine, Herbalife, Avon, Forever Living and Nu Skin. However, many consumers remain hostile to the concept of direct sales. According to the Brønnøysund Register, 30% of the population bar calls from telephone salespeople, while over 15% bar direct mail. This negative attitude to direct sales is therefore likely to hamper the channel’s future growth.
Good growth to continue
OTC healthcare is expected to continue to see good growth during the forecast period, with this being supported by widening distribution. The number of chemists/pharmacies is expected to continue to grow, particularly in rural areas. Meanwhile, grocery outlets and healthfood shops are expected to continue to expand the range of OTC healthcare on offer. Direct sales is also expected to gain a stronger presence in the country, making OTC healthcare yet more accessible to those in remote areas.
Table of contents
OTC HEALTHCARE IN NORWAY : MARKET INSIGHT
EXECUTIVE SUMMARY
Deregulation creates competition
Emergency contraception most dynamic due to growing awareness
Building brands
Direct sales significant for vitamins and dietary supplements
Good growth to continue
KEY TRENDS AND DEVELOPMENTS
Ageing population shapes growth
Deregulation creates a more competitive environment
Players increasingly focus on building up brands
MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 7 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 8 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 9 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC registration and classification
De-listing or de-reimbursement
Advertising
Packaging and labelling
Distribution
Vitamins and dietary supplements registration and classification
Generics
Consumer expenditure on health goods and medical services
Consumer Expenditure on Health Goods and Medical Services
Table 10 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
LOCAL COMPANY PROFILES - NORWAY
EUROVITA AS - OTC HEALTHCARE - NORWAY
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Eurovita as: Key Facts
Summary 3 Eurovita as: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
MöLLERCOLLETT AS - OTC HEALTHCARE - NORWAY
STRATEGIC DIRECTION
KEY FACTS
Summary 4 MöllerCollett AS: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 5 MöllerCollett AS: Production Statistics
COMPETITIVE POSITIONING
Summary 6 MöllerCollett AS: Competitive Position 2006
NYCOMED PHARMA AS - OTC HEALTHCARE - NORWAY
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Nycomed Pharma AS: Key Facts
Summary 8 Nycomed Pharma AS: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 9 Nycomed Pharma AS: Production Statistics
COMPETITIVE POSITIONING
Summary 10 Nycomed Pharma AS: Competitive Position 2006
WEIFA AS - OTC HEALTHCARE - NORWAY
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Weifa AS: Key Facts
Summary 12 Weifa AS: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 13 Weifa AS: Production Statistics
COMPETITIVE POSITIONING
Summary 14 Weifa AS: Competitive Position 2006
ANALGESICS IN NORWAY
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 11 Sales of Analgesics by Subsector: Value 2001-2006
Table 12 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 13 Herbal vs Standard Topical Analgesics 2001/2006
Table 14 Analgesics Company Shares by Retail Value 2002-2006
Table 15 Analgesics Brand Shares by Retail Value 2003-2006
Table 16 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 17 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN NORWAY
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
Table 20 Sales of Decongestants by Type: Value 2001-2006
Table 21 Sales of Decongestants by Type: % Value Growth 2001-2006
Table 22 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
Table 23 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
Table 24 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
Table 25 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
Table 26 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
DIGESTIVE REMEDIES IN NORWAY
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 27 Sales of Digestive Remedies by Subsector: Value 2001-2006
Table 28 Sales of Digestive Remedies by Subsector: % Value Growth 2001-2006
Table 29 Herbal vs Standard Digestive Remedies 2001/2006
Table 30 Digestive Remedies Company Shares by Retail Value 2002-2006
Table 31 Digestive Remedies Brand Shares by Retail Value 2003-2006
Table 32 Forecast Sales of Digestive Remedies by Subsector: Value 2006-2011
Table 33 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2006-2011
MEDICATED SKIN CARE IN NORWAY
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 34 Sales of Medicated Skin Care by Subsector: Value 2001-2006
Table 35 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
Table 36 Herbal vs Standard Medicated Skin Care 2001/2006
Table 37 Medicated Skin Care Company Shares by Retail Value 2002-2006
Table 38 Medicated Skin Care Brand Shares by Retail Value 2003-2006
Table 39 Acne Treatments Brand Shares by Retail Value 2003-2006
Table 40 Hair Loss Treatments Brand Shares by Retail Value 2003-2006
Table 41 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
Table 42 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011
VITAMINS AND DIETARY SUPPLEMENTS IN NORWAY
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 43 Sales of Vitamins and Dietary Supplements by Subsector: Value 2001-2006
Table 44 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2001-2006
Table 45 Sales of Vitamins by Type: Value 2001-2006
Table 46 Sales of Vitamins by Type: % Value Growth 2001-2006
Table 47 Vitamins and Dietary Supplements Company Shares by Retail Value 2002-2006
Table 48 Vitamins and Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 49 Vitamins Brand Shares by Retail Value 2003-2006
Table 50 Sales of Dietary Supplements by Type: Value 2001-2006
Table 51 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
Table 52 Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 53 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2006-2011
Table 54 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2006-2011
NRT SMOKING CESSATION AIDS IN NORWAY
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 55 Number of Smokers by Gender 2001-2006
Table 56 Sales of Smoking Cessation Aids by Subsector: Value 2001-2006
Table 57 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2001-2006
Table 58 Smoking Cessation Aids Company Shares by Retail Value 2002-2006
Table 59 Smoking Cessation Aids Brand Shares by Retail Value 2003-2006
Table 60 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2006-2011
Table 61 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2006-2011
EYE CARE IN NORWAY
TRENDS
SECTOR DATA
Table 62 Sales of Eye Care by Subsector: Value 2001-2006
Table 63 Sales of Eye Care by Subsector: % Value Growth 2001-2006
Table 64 Eye Care Company Shares by Retail Value 2002-2006
Table 65 Eye Care Brand Shares by Retail Value 2003-2006
Table 66 Forecast Sales of Eye Care by Subsector: Value 2006-2011
Table 67 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011
EAR CARE IN NORWAY
TRENDS
ADULT MOUTHCARE IN NORWAY
TRENDS
CALMING AND SLEEPING PRODUCTS IN NORWAY
TRENDS
WOUND TREATMENTS IN NORWAY
TRENDS
SECTOR DATA
Table 68 Sales of Wound Treatments by Subsector: Value 2001-2006
Table 69 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
Table 70 Wound Treatments Company Shares by Retail Value 2002-2006
Table 71 Wound Treatments Brand Shares by Retail Value 2003-2006
Table 72 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
Table 73 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011
EMERGENCY CONTRACEPTION IN NORWAY
TRENDS
SECTOR DATA
Table 74 Sales of Emergency Contraception by Subsector: Value 2001-2006
Table 75 Sales of Emergency Contraception by Subsector: % Value Growth 2001-2006
Table 76 Forecast Sales of Emergency Contraception by Subsector: Value 2006-2011
Table 77 Forecast Sales of Emergency Contraception by Subsector: % Value Growth 2006-2011